Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05158218 · ClinicalTrials.gov registry record · NA
Robotic Exoskeleton Gait Training in Adolescents With Cerebral Palsy
A NA study of Cerebral Palsy, sponsored by Father Flanagan's Boys' Home.
- Active
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT05158218: Active NA study of Cerebral Palsy, sponsored by Father Flanagan's Boys' Home.
NCT05158218 is a NA study of Cerebral Palsy that is active but no longer recruiting, run by Father Flanagan's Boys' Home. The registered enrollment target is 64 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05158218, a NA study of Cerebral Palsy, is active but no longer recruiting, sponsored by Father Flanagan's Boys' Home.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The study design will consist of a cohort of adolescents and young adults with cerebral palsy (CP) that will undergo a gait training protocol. All participants will complete MEG baseline brain imaging measures of their sensorimotor cortical activity, MRI brain/spinal cord imaging (previous MRI or template brain may be substituted), neurophysiological tests of the spinal cord H-reflex, and a series of mobility clinical tests. After completing the baseline tests, the participants with CP will undergo the therapeutic gait training using either traditional physical therapy or utilizing a robotic exoskeleton. After completing all of the therapeutic gait training sessions, the participants will repeat the same assessments that were completed at baseline. The two groups will be compared based on the assessments for therapeutic outcomes.
Primary Outcome
The participant will be asked to perform a series of timed (in seconds) 10-meter walking tasks.
Conditions Studied
Interventions
- BEHAVIORAL Robotic Exoskeleton Gait Therapy
- BEHAVIORAL Physical Therapy
Study Locations (1)
Nebraska
- Boys Town National Research Hospital - Boys Town
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2021-12-02 |
| Est. Completion | 2026-01-01 |
| Phase | NA |
What the registry record for NCT05158218 still lists
NCT05158218 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Cerebral Palsy appearing as the primary indexed condition, and to 2 interventions - of which Robotic Exoskeleton Gait Therapy is the first listed.
NCT05158218 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT05158218 about?
NCT05158218 is a clinical study titled "Robotic Exoskeleton Gait Training in Adolescents With Cerebral Palsy". The study design will consist of a cohort of adolescents and young adults with cerebral palsy (CP) that will undergo a gait training protocol. All participants will complete MEG baseline brain imaging measures of their sensorimotor cortical activity, MRI brain/spinal cord imaging (previous MRI or te...
What is the current status of trial NCT05158218?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2021-12-02. Estimated completion is 2026-01-01.
What conditions does trial NCT05158218 study?
This clinical trial studies the following conditions: Cerebral Palsy.
What interventions are being tested in trial NCT05158218?
The interventions under investigation include: Robotic Exoskeleton Gait Therapy (BEHAVIORAL), Physical Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05158218?
This trial is sponsored by Father Flanagan's Boys' Home, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05158218 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05158218's enrollment target sits among peer trials
64 34th of 91 higher than 58 of 91 other Cerebral Palsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Motor Training for Infants With Cerebral Palsy
RECRUITING · NA
-
Implementation of Therapy Together
RECRUITING · NA
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy
RECRUITING · NA
-
Neuromodulation of the Cortex and Spinal Cord
RECRUITING · NA
-
Effectiveness of Robotic Gait Training and Physical Therapy for Children and Youth With Cerebral Palsy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI